aod9604 academic study AOD 9604 10mg - Research Peptide Produced using quality AOD-9604 VIAL (5MG) | Pure

Subsequent elevations in NAD+ levels activate sirtuin 1 (SIRT1), a cellular regulatory enzyme dependent on NAD+ availability

Human trials limited: Clinical data shows modest or inconsistent results. Unclear mechanisms in humans: Translation from animals to people remains uncertain

Some protocols utilize twice-daily dosing (morning and early afternoon) to maintain more stable effects throughout the day, though once-daily administration appears sufficient for most users based on the sustained metabolic effects of the peptide

This difference was achieved without any change in food intake, suggesting the weight loss came from metabolic changes rather than appetite suppression